Crescent Sterling, Ltd. / ABBV
Crescent Sterling, Ltd.’s Abbvie Inc Position
Does Crescent Sterling, Ltd. own Abbvie Inc (ABBV)? Yes — 15.1K shares worth $4M (+3.39% of its 13F portfolio) as of Q2 2026, up from 14.9K shares the prior filed quarter.
Position Value
$4M
Q2 2026
Shares
15.1K
% of Portfolio
+3.39%
Quarters Held
15
currently held
Position History ABBV
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2026 | 15.1K | $4M | +3.39% |
| Q1 2026 | 14.9K | $3M | +3.14% |
| Q4 2025 | 14.9K | $3M | +3.48% |
| Q3 2025 | 15.5K | $4M | +3.78% |
| Q2 2025 | 15.6K | $3M | +3.25% |
| Q1 2025 | 17.6K | $4M | +3.78% |
| Q4 2024 | 19.7K | $3M | +3.59% |
| Q3 2024 | 20.5K | $4M | +3.86% |
| Q2 2024 | 21.2K | $4M | +3.49% |
| Q1 2024 | 21.7K | $4M | +3.60% |
| Q4 2023 | 22.0K | $3M | +3.41% |
| Q3 2023 | 22.1K | $3M | +3.48% |
| Q2 2023 | 23.0K | $3M | +2.94% |
| Q1 2023 | 22.9K | $4M | +3.55% |
| Q4 2022 | 21.6K | $3M | +3.74% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Crescent Sterling, Ltd.’s full portfolio or all institutional holders of ABBV.